Pharmacotherapy to protect the neuromuscular junction after acute organophosphorus pesticide poisoning

UMMS Affiliation

Department of Emergency Medicine, Division of Medical Toxicology

Publication Date


Document Type



Emergency Medicine | Medical Toxicology


Organophosphorus (OP) pesticide poisoning is a leading cause of morbidity and mortality in the developing world, affecting an estimated three million people annually. Much of the morbidity is directly related to muscle weakness, which develops 1-4 days after poisoning. This muscle weakness, termed the intermediate syndrome (IMS), leads to respiratory, bulbar, and proximal limb weakness and frequently necessitates the use of mechanical ventilation. While not entirely understood, the IMS is most likely due to persistently elevated acetylcholine (ACh), which activates nicotinic ACh receptors at the neuromuscular junction (NMJ). Thus, the NMJ is potentially a target-rich area for the development of new therapies for acute OP poisoning. In this manuscript, we discuss what is known about the IMS and studies investigating the use of nicotinic ACh receptor antagonists to prevent or mitigate NMJ dysfunction after acute OP poisoning.

DOI of Published Version



Ann N Y Acad Sci. 2016 Jun;1374(1):86-93. doi: 10.1111/nyas.13111. Epub 2016 Jun 3. Link to article on publisher's site

Journal/Book/Conference Title

Annals of the New York Academy of Sciences

Related Resources

Link to Article in PubMed

PubMed ID